| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20030546 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20030547 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20030308 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20029664 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20030309 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20030548 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20029665 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20030310 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20034803 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
| TVIS20043755 | HPV | ENSG00000157445.16 | protein_coding | CACNA2D3 | No | No | 55799 | Q8IZS8 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA2D3 |
|---|---|
| DrugBank ID | DB06712 |
| Drug Name | Nilvadipine |
| Target ID | BE0003563 |
| UniProt ID | Q8IZS8 |
| Regulation Type | inhibitor |
| PubMed IDs | 9249249; 10525060; 20097194; 11426839; 19634509; 10374627 |
| Citations | Furukawa T, Nukada T, Suzuki K, Fujita Y, Mori Y, Nishimura M, Yamanaka M: Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine. Br J Pharmacol. 1997 Jul;121(6):1136-40.@@Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T: Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther. 1999 Nov;291(2):464-73.@@Miyashita Y, Furukawa T, Kamegaya E, Yoshii M, Nukada T: A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine. Eur J Pharmacol. 2010 Apr 25;632(1-3):14-22. doi: 10.1016/j.ejphar.2010.01.006. Epub 2010 Jan 22.@@Murakami M, Nakagawasai O, Fujii S, Kameyama K, Murakami S, Hozumi S, Esashi A, Taniguchi R, Yanagisawa T, Tan-no K, Tadano T, Kitamura K, Kisara K: Antinociceptive action of amlodipine blocking N-type Ca2+ channels at the primary afferent neurons in mice. Eur J Pharmacol. 2001 May 11;419(2-3):175-81.@@Ogihara T, Kano T, Kakinuma C: Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling. Arzneimittelforschung. 2009;59(6):283-8. doi: 10.1055/s-0031-1296398.@@Qu YL, Sugiyama K, Ohnuki T, Hattori K, Watanabe K, Nagatomo T: Comparison of binding affinities of omega-conotoxin and amlodipine to N-type Ca2+ channels in rat brain. Zhongguo Yao Li Xue Bao. 1998 Mar;19(2):97-100. |
| Groups | Approved; Investigational |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N |
| Pathways | |
| PharmGKB | PA165958385 |
| ChEMBL | CHEMBL517427 |
